Sweden’s Sobi has kicked off a rolling biologics license application in the US for SEL-212, vying to become a new option for patients with refractory chronic gout that doesn’t respond to ...

Episode 8: Frequently asked questions about gout and uncontrolled gout Brian LaMoreaux, MD, MS, answers frequently asked questions, with topics including: how to define uncontrolled gout ...

For patients with gout who cannot get relief using standard therapies, daily life can be a painful, debilitating experience. Now, phase 3 results with a new drug from Sobi and Selecta suggests ...

The GENESIS II Total Knee System has grown to become one of the most trusted total knee systems on the market. Cutting edge instrumentation, such as the user friendly MIS system and the ream-thru ...